Subclinical atherosclerosis in menopausal women with low to medium calculated cardiovascular risk

Irene Lambrinoudaki1, Eleni Armeni, Georgios Georgiopoulos

  • 12nd Department of Obstetrics and Gynecology, 76 Vas. Sofias Ave., University of Athens, Aretaieio Hospital, Athens, Greece.

Insights

Subclinical atherosclerosis is common in healthy postmenopausal women, even with low cardiovascular risk scores. Menopausal status and related factors need greater consideration in risk assessments for primary prevention.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Women's Health

Background:

  • Cardiovascular disease (CVD) risk stratification systems do not typically include menopausal status.
  • Menopause is a known factor associated with increased cardiovascular risk.

Purpose of the Study:

  • To assess subclinical vascular disorders in healthy postmenopausal women.
  • To evaluate the prevalence of subclinical atherosclerosis in this demographic.

Main Methods:

  • Cross-sectional study of 120 healthy postmenopausal women (41-60 years) with low Heartscore (<5%).
  • Assessed traditional risk factors, years since menopause, triglycerides, waist circumference, fasting blood glucose, and HOMA-IR.
  • Measured carotid-femoral pulse wave velocity and intima-media thickness; presence of atheromatous plaques defined subclinical atherosclerosis.

Main Results:

  • Subclinical atherosclerosis was found in 55% of women; 28% had at least one plaque.
  • Higher age, years since menopause, HOMA-IR, and blood pressure were associated with subclinical atherosclerosis.
  • Years since menopause and systolic blood pressure were independent predictors. 79% of intermediate-risk women (Heartscore 2-4.9%) with menopause ≥4 years were reclassified to higher risk.

Conclusions:

  • Subclinical atherosclerosis is highly prevalent in postmenopausal women, even those with low-to-intermediate cardiovascular risk scores.
  • Menopausal status and associated factors warrant additional weighting in cardiovascular risk calculations.
  • This highlights the need for revised primary prevention strategies for this population.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...